本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

AIM ImmunoTech Inc.

8.85
-0.3183-3.47%
盘后8.850.00000.00%16:27 EDT
成交量:3,647.00
成交额:3.30万
市值:676.31万
市盈率:-0.36
高:9.51
开:9.06
低:8.85
收:9.17
数据加载中...
2024/11/27

SEC问询函

Form CORRESP - Correspondence
2024/11/16

SEC问询函

Form CORRESP - Correspondence
2024/11/15

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/31

SEC问询函

Form CORRESP - Correspondence
2024/10/01

重要事件披露

Form 8-K - Current report
2024/09/12

重要事件披露

Form 8-K - Current report
2024/09/11

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/03

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/14

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/01

重要事件披露

Form 8-K - Current report
2024/07/30

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/23

SEC问询函

Form CORRESP - Correspondence
2024/07/20

SEC问询函

Form CORRESP - Correspondence
2024/07/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/15

重要事件披露

Form 8-K - Current report
2024/07/12

SEC问询函

Form CORRESP - Correspondence
2024/07/11

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933